Research and analysis

UK-Japan genomics for better health research

Four Japanese healthcare companies have signed up or upgraded their membership to the Discovery Forum, Genomics England’s industrial partnership scheme, following joint work with SIN Japan. This brings them one step closer to forming collaborative research partnerships with UK universities and industry.


UK-Japan Genomics for Better Health Research

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use.


SIN Japan has been working with Genomics England to explore and develop opportunities for UK-Japan genomics collaborations.

Having identified untapped potential for engagement with Japan’s research community and healthcare industry, SIN Japan organised a three-day visit in December 2018 coinciding with the completion of the 100,000 Genomes Project. During the visit, several Japanese pharmaceutical and diagnostics companies expressed an interest in joining the Discovery Forum as a gateway to develop research partnerships with the UK. Three top companies signed up to become members shortly afterwards and one current member upgraded their membership to begin collaborating on a pilot study.

Genomics England was invited back to Japan in March 2019 to present on the 100,000 Genomes Project to members of the Japanese government. In June 2019, Japan’s Cabinet Office announced they would commence a 100,000 whole genome study based on the Genomics England model starting in 2020. SIN Japan will continue to support the exchange of best practice and common standards between our governments while exploring opportunities for further research collaboration.

Published 13 January 2020